Subscribe
David Alemian is the nation's top healthcare recruitment and retention expert.
Refractory angina is a loosely defined term generally referring to the persistence of life-impacting angina despite maximal antianginal medications and, when possible, coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]). Numerous novel pharmacotherapies and mechanical interventions have been proposed, and studies conducted, to treat patients with refractory angina.
MD Magazine recently spoke with Joseph F. Waeckerle, MD, FACEP, Clinical Professor of Emergency Medicine at the University of Missouri, Kansas City, and Editor Emeritus, Annals of Emergency Medicine, who has served for more than two decades on the NFL committees on brain injury.
Patients with type 2 diabetes mellitus have decreased platelet inhibition and decreased responsiveness to standard doses of clopidogrel compared with patients without diabetes. In this pilot study, we showed that increasing the maintenance dose of clopidogrel to 150 mg leads to enhanced platelet inhibition compared with the standard dose of 75 mg in patients with type 2 diabetes with suboptimal responsiveness. The clinical implications of these findings are unknown, however, and need to be evaluated in large-scale clinical trials.
A potential new candidate uses uracil to combat this cancer treatment side effect.
This review and meta-analysis assessed whether antiviral treatment given during the acute herpes zoster rash is effective at preventing postherpetic neuralgia in patients with a first-time case of shingles.
There is now substantial evidence that treatment with statins improves clinical outcomes in patients with acute as well as chronic coronary heart disease, and in older1 as well as younger patients
Our increasing ability to intervene in high-risk patients—with lower risks and greater chances for successful outcomes—is felt across the broad spectrum of cardiovascular disease. This is particularly evident in patients with dilated cardiomyopathy (DCM).
Two separate studies show the relationship between hormone replacement therapy and women's cancers.
Whole genome sequencing suggests both common and rare variants contribute to early onset drusen maculopathy.